Cite
HARVARD Citation
Sun, S. et al. (2022). Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition. Journal of clinical pharmacology. pp. 1170-1176. [Online].